Technology Access Fees. Kite shall pay Alpine a technology access fee of Five Million Dollars ($5,000,000) within thirty (30) days after the Effective Date. The technology access fee paid by Kite to Alpine under this Section 3.1(b) will be noncreditable and nonrefundable[…***…].
Technology Access Fees. The parties acknowledge that, to implement the Agreement, as modified by this Amendment, xxxxxx.xxx requires, and shall have, access to unique technologies owned by RealSelect and incorporated into the Web Sites and the servers hosting the Web Sites. As consideration for its access to these unique technologies, subject to Section 6 above, xxxxxx.xxx shall pay to RealSelect a monthly technology access fee (collectively, the "Technology Access Fees") in accordance with the following schedule: (i) for the twelve (12) month period commencing on June 30, 1999, [*] per month; (ii) for the twelve (12) month period commencing on June 30, 2000, [*] per month; and (iii) for the balance of the Initial Term, [*] per month. Xxxxxx.xxx shall make payments of all Technology Access Fees net thirty (30) days from the end of the month for which such payment was due.
Technology Access Fees. In further consideration for the Research License and for the access to the FivePrime Background Know-How during the Research Term, UCB shall pay to FivePrime non-refundable technology access fees. The technology access fees will be payable as three (3) equal payments of two million two hundred thousand dollars ($2,200,000) each, to be due and payable as follows: (a) within *** Business Days after the Effective Date; (b) on the first anniversary of the Effective Date; and (c) on the second anniversary of the Effective Date.
Technology Access Fees. (a) ImmunoGen shall pay Raven [ * ] in cash within [ * ] after [ * ].
(b) ImmunoGen shall pay Raven [ * ] in cash within [ * ] after the beginning of any [ * ].
Technology Access Fees. TDCC shall pay to Biosource a technology access fee of $10,000,000 (ten million U.S. dollars) upon the Effective Date. Within sixty (60) days after the beginning of each of the fourth, fifth, sixth and seventh Contract Year during the Research Collaboration, TDCC shall pay to Biosource an annual technology access fee of $5,000,000 (five million U.S. dollars). Within sixty (60) days after the beginning of the eighth and each subsequent Contract Year during the Research Collaboration, TDCC shall pay to Biosource an annual technology access fee of $10,000,000 (ten million U.S. dollars). All such technology access fees are non-refundable, except the fee shall be refundable in the event that the Agreement is rescinded as provided in Section 12.5.4. For avoidance of doubt, no technology access fee shall be due under this Section 6.1 for any period after the Research Collaboration ends.
Technology Access Fees. (a) Upon the Effective Date, IRC shall pay to Connetics ***.
(b) On or before ***, IRC shall pay to Connetics ***. In addition, on or before October 31, 2000, IRC shall pay to Connetics ***.
(c) If prior to October 31, 2000, IRC (a) sells or assigns to a Third Party the Assigned Technology or grants to a Third Party a license under the Assigned Technology, and (b) receives cash consideration for such sale, assignment or license, then within ten (10) business days after the receipt by IRC of such cash consideration, IRC shall pay to Connetics an amount ***. All amounts paid to Connetics under this Section 4.1.1
Technology Access Fees. Subject to the terms and conditions of this Agreement, the Company has agreed to pay a Technology Access Fee (as defined in the Channel Agreement) valued at three million dollars ($3,000,000) to Intrexon, which Technology Access Fee may be paid either in cash or Company’s Common Stock at Company’s sole discretion. Payment for the Technology Access Fee will be made at the Closing (as hereinafter defined) in accord with this Section 1.1. Company, in its discretion, shall either (i) pay to Intrexon three million dollars ($3,000,000) cash at the Technology Access Fee Closing (as defined below), or (ii) pay Intrexon at the Technology Access Fee Closing the Technology Access Fee due by issuing to Intrexon twenty-four million (24,000,000) shares of Common Stock of Company (the “Technology Access Fee Shares”) in accord with this Section 1.1.
Technology Access Fees. In consideration for the exclusive rights granted under the Agreement, Pioneer will pay NBY the following amounts as set forth below:
4.1.1 Pioneer shall pay NBY a technology access fee in the total amount of US$500,000, which will paid as follows,
4.1.1.1 US$250,000 is payable immediately upon the execution of this Agreement;
4.1.1.2 US$250,000 shall be due and payable on or before December 15, 2012.
4.1.2 Within thirty (30) days of the submission of the first Marketing Approval Application for the Product to a relevant Regulatory Authority in any country in the Territory except Singapore, Hong Kong or Malaysia, Pioneer shall pay NBY a technology access fee in the amount of US$100,000; and
4.1.3 Within thirty (30) days of the receipt of the first MAA Approval of the Product from a Regulatory Authority of any country in the Territory except Singapore, Hong Kong or Malaysia, Pioneer shall pay NBY a technology access fee in the amount of US$100,000.
Technology Access Fees. In consideration for the exclusive rights granted under the Agreement, Pioneer will pay NBY the following amounts as set forth below:
(i) Within ten (10) days of the execution of this Agreement, Pioneer shall pay NBY a technology access fee in the amount of US$312,500;
(ii) Within thirty (30) days of the submission of the first Marketing Approval Application for the Product to SFDA, Pioneer shall pay NBY a technology access fee in the amount of US$312,500; and
(iii) Within thirty (30) days of the receipt of a MAA Approval of the Product from SFDA, Pioneer shall pay NBY a technology access fee in the amount of US$625,000. For clarity, in the event (A) NBY fails to submit a Marketing Approval Application for the Product in the Territory to SFDA or (B) the SFDA determines that additional development of the Product is necessary for MAA Approval in the Territory and either (i) Pioneer does not elect to co-fund the Additional Development (as defined in Section 6.2) within sixty (60) days from receiving NBY’s notice thereof, or (ii) Pioneer elects to co-fund the Additional Development, but after the performance of such Additional Development and filing of the applicable Marketing Approval Application based thereon, NBY is still unable to obtain MAA Approval for the Product, then NBY will refund Pioneer US$312,500.
Technology Access Fees. Three (3) months after the Effective Date, Genentech shall pay to Sangamo an initial technology access fee of $[***]. Thereafter, on each anniversary of the Effective Date (starting with the first anniversary) prior to the First Commercial Sale of the first Licensed Product, Genentech shall pay to Sangamo an annual technology access fee of $[***].
